Screener
Vaxcyte, Inc. PCVX EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
FAQ
- What is Vaxcyte, Inc.'s EBIT?
- Vaxcyte, Inc. (PCVX) reported EBIT of -$345.85M in Q1 2026.
- How has Vaxcyte, Inc.'s EBIT changed year-over-year?
- Vaxcyte, Inc.'s EBIT decreased by 91.3% year-over-year, from -$180.79M to -$345.85M.
- What is the long-term trend for Vaxcyte, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s EBIT has grown at a 72.8% compound annual growth rate (CAGR), from -$103.67M to -$923.68M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Vaxcyte, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude